Discrimination of single-nucleotide polymorphisms in human DNA using peptide nucleic acid probes detected by MALDI-TOF mass spectrometry

被引:131
作者
Ross, PL
Lee, K
Belgrader, P
机构
[1] DNA Technology Development Branch, Ctr. for Molec. and Medical Genetics, Armed Forces Institute of Pathology, Rockville
[2] Univ. of Maryland - Baltimore County, Baltimore, MD 21228
关键词
D O I
10.1021/ac9703966
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Human genomic and mitochondrial DNA contain large numbers of single-nucleotide polymorphisms (SNPs), many of which are linked to known diseases, Rapid and accurate genetic screening for important SNPs requires a general methodology which is easily implemented. We present here an approach to SNP discrimination based on high-specificity hybridization of peptide nucleic acid (PNA) probes to PCR-amplified DNA The assay is directly applied to polymorphisms located within hypervariable region 1 of the human mitochondrial genome and type 1 suballeles of the human leukocyte antigen DQ alpha gene, Captured, single-stranded DNA molecules prepared by PCR amplification;are hybridized with PNA probes in an allele-specific fashion. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) is then used for rapid, precise, and unambiguous detection and identification of the hybridized PNA probes, Since PNA oligomers bind strongly to complementary DNA under minimal salt conditions, the use of PNA probes is compatible with MALDI-TOFMS. The unparalleled ability of MALDI-TOFMS analysis in terms of molecular weight resolution and accuracy, in conjunction with the highly specific PNA hybridization afforded by this method, offers promise for development into a multiplexed, high-throughput screening technique.
引用
收藏
页码:4197 / 4202
页数:6
相关论文
共 32 条
  • [1] SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME
    ANDERSON, S
    BANKIER, AT
    BARRELL, BG
    DEBRUIJN, MHL
    COULSON, AR
    DROUIN, J
    EPERON, IC
    NIERLICH, DP
    ROE, BA
    SANGER, F
    SCHREIER, PH
    SMITH, AJH
    STADEN, R
    YOUNG, IG
    [J]. NATURE, 1981, 290 (5806) : 457 - 465
  • [2] DIAGNOSIS OF GENETIC-DISORDERS AT THE DNA LEVEL
    ANTONARAKIS, SE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (03) : 153 - 163
  • [4] Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia
    Baron, H
    Fung, S
    Aydin, A
    Bahring, S
    Luft, FC
    Schuster, H
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (10) : 1279 - 1282
  • [5] BELGRADER P, 1996, GENOME SCI TECHNOL, V1, P77, DOI DOI 10.1089/GST.1996.1.77
  • [6] BOEHM CD, 1989, CLIN CHEM, V35, P1843
  • [7] Burlingame AL, 1996, ANAL CHEM, V68, pR599, DOI 10.1021/a1960021u
  • [8] Peptide nucleic acid characterization by MALDI-TOF mass spectrometry
    Butler, JM
    JiangBaucom, P
    Huang, M
    Belgrader, P
    Girard, J
    [J]. ANALYTICAL CHEMISTRY, 1996, 68 (18) : 3283 - 3287
  • [9] Screening for genetic mutations
    Carlsson, C
    Jonsson, M
    Norden, B
    Dulay, MT
    Zare, RN
    Noolandi, J
    Nielsen, PE
    Tsui, LC
    Zielenski, J
    [J]. NATURE, 1996, 380 (6571) : 207 - 207
  • [10] DETECTION OF DELTA-F508 MUTATION OF THE CYSTIC-FIBROSIS GENE BY MATRIX-ASSISTED LASER-DESORPTION IONIZATION MASS-SPECTROMETRY
    CHANG, LY
    TANG, K
    SCHELL, M
    RINGELBERG, C
    MATTESON, KJ
    ALLMAN, SL
    CHEN, CH
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1995, 9 (09) : 772 - 774